SevenOneSeven Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,595
Closed -$259K 59
2022
Q2
$259K Buy
1,595
+62
+4% +$9.81K 0.6% 41
2022
Q1
$288K Sell
1,533
-13
-0.8% -$2.47K 0.6% 42
2021
Q4
$409K Sell
1,546
-56
-3% -$15.1K 0.81% 34
2021
Q3
$463K Buy
1,602
+18
+1% +$4.62K 1.17% 15
2021
Q2
$316K Buy
+1,584
New +$307K 0.82% 34

Other funds holding RGEN

SevenOneSeven Capital Management's RGEN Position: Q3 2022 in Review

SevenOneSeven Capital Management sold out of Repligen (RGEN) in Q3 2022, closing a stake of 1,595 shares — an estimated $259K sold.

SevenOneSeven Capital Management first reported a position in RGEN in Q2 2021 and held it in 5 quarters. The position peaked at $463K in Q3 2021. 434 funds tracked by Wall St. Rank hold RGEN as of Q3 2022.

  • SevenOneSeven Capital Management reported no remaining Repligen position as of Q3 2022 after selling out during the quarter.
  • SevenOneSeven Capital Management sold 1,595 Repligen shares in Q3 2022, an estimated $259K.
  • SevenOneSeven Capital Management first reported a position in Repligen in Q2 2021 and held it in 5 quarters.
  • SevenOneSeven Capital Management's Repligen position peaked at $463K in Q3 2021.
  • 434 funds tracked by Wall St. Rank held Repligen as of Q3 2022.

Based on SevenOneSeven Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.